Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy

Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy

Background: Programmed cell death-ligand 1 (PD-L1) is present in a subgroup of cancer patients who may be favorable targets for immune checkpoint inhibitor therapies. However, the significance of the PD-L1 expression in esophageal squamous cell carcinoma (ESCC) patients receiving neoadjuvant chemora...

Full description

Bibliographic Details
Main Authors: Wan-Ting Huang, Hung-I Lu, Yu-Ming Wang, Yen-Hao Chen, Chien-Ming Lo, Wei-Che Lin, Ya-Chun Lan, Ling-Huei Tseng, Shau-Hsuan Li
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Journal of Clinical Medicine
Subjects:
esophageal cancer
squamous cell carcinoma
pd-l1
chemoradiotherapy
immunotherapy
Online Access:https://www.mdpi.com/2077-0383/8/11/1864

Internet

https://www.mdpi.com/2077-0383/8/11/1864

Similar Items